CoChat

Dysfunctional adiposity index as a marker of adipose tissue morpho-functional abnormalities and metabolic disorders in apparently healthy subjects

Open access
Reyes-Barrera, Juan, Sainz-Escárrega, Victor H., Medina-Urritia, Aida X., Jorge-Galarza, Esteban, Osorio-Alonso, Horacio, Torres-Tamayo, Margarita, Leal-Escobar, Gabriela, Posadas-Romero, Carlos, Torre-Villalvazo, Ivan, Juárez-Rojas, Juan G. · 2021 · Adipocyte

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Compared to body mass index, waist circumference (WC), and adiposity measurements, adipose tissue (AT) morpho-functionality evaluations are better predictors of cardiometabolic abnormalities (CA). The present study establishes a dysfunctional adiposity index (DAI) as an early marker of CA based on adipocytes morpho-functional abnormalities. DAI was established in 340 subjects without cardiovascular risk factors selected from a cross-sectional study (n=1600). Then, DAI was calculated in 36 healthy subjects who underwent subcutaneous AT biopsy. The correlation of DAI with adipocyte morphology (size/number) and functionality (adiponectin/leptin ratio) was analyzed. The DAI cut-off point was identified and its independent association with CA was determined in 1418 subjects from the cross-sectional study. The constant parameters to calculate the DAI were [WC/[22.79+[2.68*BMI]]]*[triglycerides (TG, mmol/L)/1.37]*[1.19/high density lipoprotein-cholesterol (HDL-C, mmol/L)] for males, and [WC/[24.02+[2.37*BMI]]]*[TG(mmol/L)/1.32]*[1.43/HDL-C(mmol/L)] for females. DAI correlated with adipocytes mean area, adipocyte number and adiponectin/leptin ratio. DAI ≥1.065 was independently associated with diabetes, non-alcoholic fatty liver disease, subclinical atherosclerosis, and hypertension. The present study highlights that DAI is associated with early CA independently of adiposity and other risk factors. Since DAI is obtained using accessible parameters, it can be easily incorporated into clinical practice for early identification of AT abnormalities in apparently healthy subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21623945.2021.1893452

Cites

Statistics

Figures

Figure 1. Study flowchart. 1a) GEA study. Diabetes defined as glucose >7.0 mmol/L, hypoglycaemic treatment or previous diagnosis; hypertension as self-reported treatment with antihypertensive medications or systolic/diastolic blood pressure ≥140/90 mmHg; subclinical atherosclerosis as coronary artery calcium >0; non-alcoholic fatty liver disease as spleen-liver attenuation ratio <1.0; and low HDL-cholesterol as values <1.03 mmol/L or <1.29 mmol/L for men or women; respectively. 1b) Study of the adipose tissue functionality. HOMA-IR: homoeostatic model assessment of insulin resistance; HDL: high-density lipoprotein
Figure 1. Study flowchart. 1a) GEA study. Diabetes defined as glucose >7.0 mmol/L, hypoglycaemic treatment or previous diagnosis; hypertension as self-reported treatment with antihypertensive medications or systolic/diastolic blood pressure ≥140/90 mmHg; subclinical atherosclerosis as coronary artery calcium >0; non-alcoholic fatty liver disease as spleen-liver attenuation ratio <1.0; and low HDL-cholesterol as values <1.03 mmol/L or <1.29 mmol/L for men or women; respectively. 1b) Study of the adipose tissue functionality. HOMA-IR: homoeostatic model assessment of insulin resistance; HDL: high-density lipoproteinCC BY · PubMed Central
Figure 2. Correlation of dysfunctional adiposity index with functional (2a) and morphological (2b) characteristics of adipose tissue in 36 healthy subjects. * Spearman correlation coefficient, the shaded area represents the 95% confidence interval
Figure 2. Correlation of dysfunctional adiposity index with functional (2a) and morphological (2b) characteristics of adipose tissue in 36 healthy subjects. * Spearman correlation coefficient, the shaded area represents the 95% confidence intervalCC BY · PubMed Central
Figure 3. Correlation of dysfunctional adiposity index with systematic inflammation markers in 36 healthy subjects. hs-CRP: high-sensitivity C-reactive protein; IL: interleukin; MCP-1: monocyte chemoatractant protein-1. * Spearman correlation coefficient, shaded area represents the 95% confidence interval
Figure 3. Correlation of dysfunctional adiposity index with systematic inflammation markers in 36 healthy subjects. hs-CRP: high-sensitivity C-reactive protein; IL: interleukin; MCP-1: monocyte chemoatractant protein-1. * Spearman correlation coefficient, shaded area represents the 95% confidence intervalCC BY · PubMed Central
Figure 4. Receiver operating characteristic (ROC) curve to predict the homoeostatic model assessment of insulin resistance (HOMA-IR) ≥2.09. AUC: area under the curve; SE: standard error; CI: confidence interval. * This represents the median value in 36 healthy subjects
Figure 4. Receiver operating characteristic (ROC) curve to predict the homoeostatic model assessment of insulin resistance (HOMA-IR) ≥2.09. AUC: area under the curve; SE: standard error; CI: confidence interval. * This represents the median value in 36 healthy subjectsCC BY · PubMed Central
Figure 5. Association of high dysfunctional adiposity index (>1.065) with cardiometabolic abnormalities in 1418 subjects without a history of cardiovascular disease. Diabetes is defined as glucose >7.0 mmol/L, hypoglycaemic treatment or previous diagnosis; non-alcoholic fatty liver disease as spleen-liver attenuation ratio <1.0; subclinical atherosclerosis as coronary artery calcium >0, and hypertension as self-reported treatment with antihypertensive medications or systolic/diastolic blood pressure ≥140/90 mmHg. * Multiple logistic regression analysis adjusted by age, sex, and tobacco use
Figure 5. Association of high dysfunctional adiposity index (>1.065) with cardiometabolic abnormalities in 1418 subjects without a history of cardiovascular disease. Diabetes is defined as glucose >7.0 mmol/L, hypoglycaemic treatment or previous diagnosis; non-alcoholic fatty liver disease as spleen-liver attenuation ratio <1.0; subclinical atherosclerosis as coronary artery calcium >0, and hypertension as self-reported treatment with antihypertensive medications or systolic/diastolic blood pressure ≥140/90 mmHg. * Multiple logistic regression analysis adjusted by age, sex, and tobacco useCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 39 · Cited by 36

Research works printed but not linked: 4

  1. Baker P, 2020, Obes Rev, 1
  2. Caputo T, 2020, Cell Mol Life Sci
  3. González-Salazar MC, 2014, Gac Med Mex, 150, 39
  4. Chachopoulos V, 2017, J Vis Exp, 127, 55593

Metadata

Authors
Reyes-Barrera, J., Sainz-Escárrega, V. H., Medina-Urritia, A. X., Jorge-Galarza, E., Osorio-Alonso, H., Torres-Tamayo, M., Leal-Escobar, G., Posadas-Romero, C., Torre-Villalvazo, I., & Juárez-Rojas, J. G.
Affiliations
  • Instituto Nacional de Cardiología (MX)
  • Department of Cardiothoracic Surgery, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, México
  • Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, México
  • Department of Cardio-Renal Physiopathology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, México
  • Department of Nutrition Physiology, Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán, Mexico City, México
Corresponding author
Juárez-Rojas, Juan G.
Venue
Adipocyte
Published
2021-01-01
Volume
10
Issue
1
Pages
142-152
ISSN
  • 2162-3945 (ISSN-L)
  • 2162-397X
OpenAlex
W3136865892
Cited by
36
References
39
Citations by year
2026: 7 · 2025: 8 · 2024: 4 · 2023: 8 · 2022: 7 · 2021: 2
FWCI
3.78
Type
journal article
Language
en
Open access
Locations
  • Adipocyte (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Instituto Nacional de Cardiología Ignacio Chávez
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
adipose tissue dysfunction, adipocyte morphology, adipocyte number, adiponectin/leptin ratio, cardiometabolic abnormalities, waist circumference, triglycerides, HDL cholesterol, diabetes mellitus, non-alcoholic fatty liver disease, subclinical atherosclerosis, hypertension, early risk markers
MeSH terms
Adipose Tissue, Adult, Aged, Cardiovascular Diseases, Female, Humans, Male, Metabolic Diseases, Middle Aged, Biomarkers, Body Mass Index, Adiposity, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dysfunctional adiposity index as a marker of adipose tissue morpho-functional abnormalities and metabolic disorders in apparently healthy subjects. https://app.cochat.ai/papers/10.1080/21623945.2021.1893452
The paper
Reyes-Barrera, J., Sainz-Escárrega, V. H., Medina-Urritia, A. X., Jorge-Galarza, E., Osorio-Alonso, H., Torres-Tamayo, M., Leal-Escobar, G., Posadas-Romero, C., Torre-Villalvazo, I., & Juárez-Rojas, J. G. (2021). Dysfunctional adiposity index as a marker of adipose tissue morpho-functional abnormalities and metabolic disorders in apparently healthy subjects. Adipocyte. https://doi.org/10.1080/21623945.2021.1893452

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.